# Davita Inc.: filings

DVA · NYSE · CIK 927066 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dva.md) · [Financials](/companies/dva/financials.md) · [Filings](/companies/dva/filings.md) · [Insiders](/companies/dva/insiders.md)

## Reports and events: 337 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1585, 8-K 239, 10-Q 54, SC 13G/A 40, 3 32, 144 30, DEFA14A 23, 425 22, 4/A 21, DEF 14A 19, 10-K 18, 11-K 18, UPLOAD 17, CORRESP 14, CT ORDER 10, 424B5 9, SC TO-I/A 9, SC 13G 7, S-8 6, ARS 4, FWP 4, S-3ASR 4, 10-Q/A 3, NO ACT 3, PRE 14A 3, S-4/A 3, SCHEDULE 13G/A 3, SC TO-C 3, 10-K/A 2, 3/A 2, 5 2, 8-K/A 2, PX14A6G 2, SC TO-I 2, 25-NSE 1, 424B3 1, EFFECT 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 17:03 ET | [10-Q](/filings/0000927066-26-000134.md) | Quarterly report, period 2026-09-30 | 0000927066-26-000134 |
| 2026-10-29 | 16:06 ET | [8-K](/filings/0000927066-26-000132.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-26-000132 |
| 2026-08-04 | 17:03 ET | [10-Q](/filings/0000927066-26-000108.md) | Quarterly report, period 2026-06-30 | 0000927066-26-000108 |
| 2026-08-04 | 16:08 ET | [8-K](/filings/0000927066-26-000105.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-26-000105 |
| 2026-06-08 | 16:33 ET | [8-K](/filings/0001206774-26-000316.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001206774-26-000316 |
| 2026-05-05 | 17:03 ET | [10-Q](/filings/0000927066-26-000062.md) | Quarterly report, period 2026-03-31 | 0000927066-26-000062 |
| 2026-05-05 | 16:09 ET | [8-K](/filings/0000927066-26-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-26-000060 |
| 2026-04-22 | 16:30 ET | [DEF 14A](/filings/0000927066-26-000053.md) | Proxy statement, period 2025-12-31 | 0000927066-26-000053 |
| 2026-02-11 | 16:06 ET | [10-K](/filings/0000927066-26-000012.md) | Annual report, period 2025-12-31 | 0000927066-26-000012 |
| 2026-02-02 | 16:07 ET | [8-K](/filings/0000927066-26-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-26-000004 |
| 2025-11-25 | 17:01 ET | [8-K](/filings/0001206774-25-000750.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001206774-25-000750 |
| 2025-10-29 | 17:05 ET | [10-Q](/filings/0000927066-25-000165.md) | Quarterly report, period 2025-09-30 | 0000927066-25-000165 |
| 2025-10-29 | 16:09 ET | [8-K](/filings/0000927066-25-000163.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-25-000163 |
| 2025-08-20 | 16:09 ET | [8-K](/filings/0000927066-25-000154.md) | 8.01 Other events | 0000927066-25-000154 |
| 2025-08-05 | 17:03 ET | [10-Q](/filings/0000927066-25-000124.md) | Quarterly report, period 2025-06-30 | 0000927066-25-000124 |
| 2025-08-05 | 16:07 ET | [8-K](/filings/0000927066-25-000122.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-25-000122 |
| 2025-07-17 | 16:01 ET | [8-K](/filings/0001193125-25-160501.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-160501 |
| 2025-06-09 | 16:31 ET | [8-K](/filings/0000927066-25-000107.md) | 5.07 Shareholder vote results | 0000927066-25-000107 |
| 2025-05-23 | 16:28 ET | [8-K](/filings/0001206774-25-000378.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001206774-25-000378 |
| 2025-05-20 | 16:58 ET | [8-K](/filings/0001206774-25-000369.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001206774-25-000369 |
| 2025-05-20 | 09:07 ET | [8-K](/filings/0001206774-25-000368.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001206774-25-000368 |
| 2025-05-12 | 17:02 ET | [10-Q](/filings/0000927066-25-000087.md) | Quarterly report, period 2025-03-31 | 0000927066-25-000087 |
| 2025-05-12 | 16:08 ET | [8-K](/filings/0000927066-25-000085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-25-000085 |
| 2025-04-24 | 17:18 ET | [DEF 14A](/filings/0000927066-25-000076.md) | Proxy statement, period 2025-06-05 | 0000927066-25-000076 |
| 2025-04-14 | 06:54 ET | [8-K](/filings/0001193125-25-079593.md) | 8.01 Other events | 0001193125-25-079593 |
| 2025-02-13 | 17:25 ET | [10-K](/filings/0000927066-25-000012.md) | Annual report, period 2024-12-31 | 0000927066-25-000012 |
| 2025-02-13 | 16:07 ET | [8-K](/filings/0000927066-25-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-25-000009 |
| 2024-10-29 | 17:04 ET | [10-Q](/filings/0000927066-24-000179.md) | Quarterly report, period 2024-09-30 | 0000927066-24-000179 |
| 2024-10-29 | 16:08 ET | [8-K](/filings/0000927066-24-000177.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-24-000177 |
| 2024-09-13 | 16:15 ET | [8-K](/filings/0001206774-24-000897.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001206774-24-000897 |
| 2024-09-05 | 17:12 ET | [8-K](/filings/0000927066-24-000162.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000927066-24-000162 |
| 2024-08-14 | 08:30 ET | [8-K](/filings/0001206774-24-000784.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001206774-24-000784 |
| 2024-08-09 | 18:17 ET | [8-K](/filings/0001206774-24-000776.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001206774-24-000776 |
| 2024-08-08 | 09:32 ET | [8-K](/filings/0001206774-24-000769.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001206774-24-000769 |
| 2024-08-06 | 17:03 ET | [10-Q](/filings/0000927066-24-000128.md) | Quarterly report, period 2024-06-30 | 0000927066-24-000128 |
| 2024-08-06 | 16:10 ET | [8-K](/filings/0000927066-24-000126.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-24-000126 |
| 2024-06-10 | 17:14 ET | [8-K](/filings/0000927066-24-000115.md) | 5.07 Shareholder vote results | 0000927066-24-000115 |
| 2024-05-13 | 06:16 ET | [8-K](/filings/0000927066-24-000093.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000927066-24-000093 |
| 2024-05-02 | 16:12 ET | [10-Q](/filings/0000927066-24-000090.md) | Quarterly report, period 2024-03-31 | 0000927066-24-000090 |
| 2024-05-02 | 16:10 ET | [8-K](/filings/0000927066-24-000089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-24-000089 |
| 2024-05-01 | 16:45 ET | [8-K](/filings/0000927066-24-000083.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000927066-24-000083 |
| 2024-04-26 | 16:06 ET | [DEF 14A](/filings/0000927066-24-000078.md) | Proxy statement, period 2023-12-31 | 0000927066-24-000078 |
| 2024-04-10 | 16:43 ET | [8-K](/filings/0000927066-24-000068.md) | 5.02 Departure or appointment of officers or directors | 0000927066-24-000068 |
| 2024-02-14 | 17:01 ET | [10-K](/filings/0000927066-24-000013.md) | Annual report, period 2023-12-31 | 0000927066-24-000013 |
| 2024-02-13 | 16:11 ET | [8-K](/filings/0000927066-24-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-24-000005 |
| 2023-11-07 | 17:08 ET | [10-Q](/filings/0000927066-23-000209.md) | Quarterly report, period 2023-09-30 | 0000927066-23-000209 |
| 2023-11-07 | 16:11 ET | [8-K](/filings/0000927066-23-000207.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-23-000207 |
| 2023-08-03 | 17:07 ET | [10-Q](/filings/0000927066-23-000178.md) | Quarterly report, period 2023-06-30 | 0000927066-23-000178 |
| 2023-08-03 | 16:08 ET | [8-K](/filings/0000927066-23-000175.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-23-000175 |
| 2023-07-25 | 16:42 ET | [8-K](/filings/0000927066-23-000170.md) | 5.02 Departure or appointment of officers or directors | 0000927066-23-000170 |

Page 1 of 7. [Older](/companies/dva/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 20:16 ET. No prices; not investment advice.